Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On January 27, 2026, Cognition Therapeutics, Inc. (the “Company”) issued a press release announcing the completion of its Tye C meeting with the U
Financial Statements and Exhibits. (d) Exhibits The following exhibits are being furnished herewith: Exhibit No. Document 99.1 Press Release, dated January 27,